Content area

|
|

Genetiske test er kommercielt tilgængelige men inkomplette

Forbrugerens spytprøve indsendes direkte til det private firma, der tester arvematerialet på single nucleotide polymorphism-chips. Foto: Arense Gulbech Jensen.
Forfatter(e)
Solvej Videbæk Andersen Health, Aarhus Universitet Ugeskr Læger 2014;176:V08130517
Reference: 
Ugeskr Læger 2014;176:V08130517
Blad nummer: 
Sidetal: 
2454-2456
Genetic tests are available but they are based on incomplete data
Direct-to-consumer genome-wide profiling is a rising phenomenon. The risk estimates given by these genetic tests are based on scientifically true but incomplete data. The consumers expect to be given personal individualized risk estimates for multifactorial diseases, and they are, but the risk estimates are only based on the small fraction of hereditability that we are able to explain by common genetic markers, and therefore the dimensions of other contributing factors need to be understood before one can realise the validity of a risk estimate for a multifactorial disease.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Hassan Ali Eskandarani | 07/12
3 kommentarer
af Mats Lindberg | 06/12
1 Kommentar
af Jens Ole Mathiesen | 06/12
2 kommentarer
af Jørn Bøgh | 06/12
2 kommentarer
af Anna Inger Roe Rasmussen | 02/12
18 kommentarer
af Troels Krogh Nielsen | 30/11
7 kommentarer
af Flemming Juul Hansen | 29/11
1 Kommentar